Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
August-2015 Volume 10 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2015 Volume 10 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa

  • Authors:
    • Soichiro Kawata
    • Kazuo Yashima
    • Sohei Yamamoto
    • Shuji Sasaki
    • Yohei Takeda
    • Akihiro Hayashi
    • Kazuya Matsumoto
    • Koichiro Kawaguchi
    • Kenichi Harada
    • Yoshikazu Murawaki
  • View Affiliations / Copyright

    Affiliations: Division of Medicine and Clinical Science, Faculty of Medicine, Tottori University, Nishicho, Yonago 683‑8504, Japan
    Copyright: © Kawata et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 737-743
    |
    Published online on: June 9, 2015
       https://doi.org/10.3892/ol.2015.3342
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

A number of tumor-associated genes have been associated with gastric cancer development. The present study evaluated differences in tumor‑associated protein expression and phenotype among early gastric neoplasms, and correlated these data with those of the background mucosa. The expression of activation‑induced cytidine deaminase (AID), p53 and MLH1 in 151 early gastric neoplasms [22 gastric adenomas, 92 intramucosal carcinomas (MCs), and 37 submucosal carcinomas (SMCs)] was examined immunohistochemically and compared with that of the corresponding background mucosal condition. The cellular phenotypes of the neoplasms and the corresponding background intestinal metaplasia were also determined. Aberrant AID, p53 and MLH1 expression was detected in 36.4, 0 and 0% of the adenomas, in 35.9, 32.6 and 16.3% of the MCs, and in 56.8, 62.2 and 21.6% of the SMCs, respectively. The frequency of aberrant AID and p53 expression in the SMCs was significantly increased compared with that in the MCs (AID, P<0.05; p53, P<0.01). Aberrant AID expression was significantly associated with p53 overexpression in the SMCs (P<0.01), but not in the adenomas or MCs. In addition, AID expression was associated with the severity of mononuclear cell activity in the non‑cancerous mucosa adjacent to the tumor (P<0.05), particularly in the SMC cases. The percentage of MCs (34.8%) and SMCs (24.3%) that were of the gastric phenotype was higher compared with the percentage of adenomas (18.2%). These results indicated that p53 and MLH1 expression and a gastric phenotype may be important for carcinogenesis, and that chronic inflammation and AID and p53 expression are associated with submucosal progression.
View Figures

Figure 1

Figure 2

View References

1 

Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Correa P: Human gastric carcinogenesis: A multistep and multifactorial process - First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 52:6735–6740. 1992.PubMed/NCBI

3 

Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Sipponen P and Kimura K: Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time. Eur J Gastroenterol Hepatol. 6:(Suppl 1). S79–S83. 1994.PubMed/NCBI

5 

Tamura G: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 12:192–198. 2006.PubMed/NCBI

6 

Yamazaki K, Tajima Y, Makino R, et al: Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol. 12:3803–3809. 2006.PubMed/NCBI

7 

Hong SH, Kim HG, Chung WB, et al: DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci. 20:236–241. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Fleisher AS, Esteller M, Wang S, et al: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59:1090–1095. 1999.PubMed/NCBI

9 

Chiba T, Marusawa H and Ushijima T: Inflammation-associated cancer development in digestive organs: Mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 143:550–563. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y and Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553–563. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Okazaki IM, Hiai H, Kakazu N, et al: Constitutive expression of AID leads to tumorigenesis. J Exp Med. 197:1173–1181. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Matsumoto Y, Marusawa H, Kinoshita K, et al: Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 13:470–476. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI

14 

Nakamura K, Sugano H and Takagi K: Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearance. Gan. 59:251–258. 1968.PubMed/NCBI

15 

Egashira Y, Shimoda T and Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int. 49:55–61. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Yoshino T, Shimoda T, Saito A, et al: Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach Intestine. 34:513–525. 1999.

17 

Koseki K, Takizawa T, Koike M, Ito M, Nihei Z and Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89:724–732. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Japanese Gastric Cancer Association, . Japanese Classification of Gastric Carcinoma. 13th. Kanehara & Co., Ltd.; Tokyo: 1998, (In Japanese).

19 

Schlemper RJ, Riddell RH, Kato Y, et al: The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 47:251–255. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996. View Article : Google Scholar : PubMed/NCBI

21 

Andachi H, Yashima K, Koda M, et al: Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer. 87:441–445. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Baek MJ, Kang H, Kim SE, et al: Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer. 85:1147–1152. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Niwa T, Ikehara Y, Nakanishi H, et al: Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem. 53:75–85. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Morisawa T, Marusawa H, Ueda Y, et al: Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer. 123:2735–2740. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Kim CJ, Song JH, Cho YG, et al: Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol. 28:333–339. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Takeda Y, Yashima K, Hayashi A, et al: Expression of AID, P53 and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol. 4:131–137. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Goto A, Hirahashi M, Osada M, et al: Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 458:717–724. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS and Hainaut P: Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 21:7435–7451. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Saeki H, Ohno S, Miyazaki M, et al: p53 protein accumulation in multiple oesophageal squamous cell carcinoma: Relationship to risk factors. Oncology. 62:175–179. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Kozack R, Seo KY, Jelinsky SA and Loechler EL: Toward an understanding of the role of DNA adduct conformation in defining mutagenic mechanism based on studies of the major adduct (formed at N(2)-dG) of the potent environmental carcinogen, benzo[a]pyrene. Mutat Res. 450:41–59. 2000. View Article : Google Scholar : PubMed/NCBI

31 

Viala J, Chaput C, Boneca IG, et al: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 5:1166–1174. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Endo Y, Marusawa H, Kou T, et al: Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology. 135:889–898. 898.e1–898e.3. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Endo Y, Marusawa H, Kinoshita K, et al: Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene. 26:5587–5595. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Komori J, Marusawa H, Machimoto T, et al: Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology. 47:888–896. 2008. View Article : Google Scholar : PubMed/NCBI

35 

Nagata N, Akiyama J, Marusawa H, et al: Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication. J Gastroenterol. 49:427–435. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Kang DW, Hwang WC, Park MH, et al: Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells. Oncogene. 32:3531–3542. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Sugai T, Habano W, Endoh M, et al: Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer. 127:2500–2509. 2010. View Article : Google Scholar : PubMed/NCBI

38 

Fritz EL and Papavasiliou FN: Cytidine deaminases: AIDing DNA demethylation? Genes Dev. 24:2107–2114. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Tajima Y, Shimoda T, Nakanishi Y, et al: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology. 61:212–220. 2001. View Article : Google Scholar : PubMed/NCBI

40 

Tsukashita S, Kushima R, Bamba M, Sugihara H and Hattori T: MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer. 94:166–170. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Yuasa H, Inada K, Watanabe H and Tatematsu M: A phenotypic shift from gastric-intestinal to solely intestinal cell types in intestinal metaplasia in rat stomach following treatment with X-rays. J Toxicol Pathol. 15:85–93. 2002. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kawata S, Yashima K, Yamamoto S, Sasaki S, Takeda Y, Hayashi A, Matsumoto K, Kawaguchi K, Harada K, Murawaki Y, Murawaki Y, et al: AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa. Oncol Lett 10: 737-743, 2015.
APA
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A. ... Murawaki, Y. (2015). AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa. Oncology Letters, 10, 737-743. https://doi.org/10.3892/ol.2015.3342
MLA
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A., Matsumoto, K., Kawaguchi, K., Harada, K., Murawaki, Y."AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa". Oncology Letters 10.2 (2015): 737-743.
Chicago
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A., Matsumoto, K., Kawaguchi, K., Harada, K., Murawaki, Y."AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa". Oncology Letters 10, no. 2 (2015): 737-743. https://doi.org/10.3892/ol.2015.3342
Copy and paste a formatted citation
x
Spandidos Publications style
Kawata S, Yashima K, Yamamoto S, Sasaki S, Takeda Y, Hayashi A, Matsumoto K, Kawaguchi K, Harada K, Murawaki Y, Murawaki Y, et al: AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa. Oncol Lett 10: 737-743, 2015.
APA
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A. ... Murawaki, Y. (2015). AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa. Oncology Letters, 10, 737-743. https://doi.org/10.3892/ol.2015.3342
MLA
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A., Matsumoto, K., Kawaguchi, K., Harada, K., Murawaki, Y."AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa". Oncology Letters 10.2 (2015): 737-743.
Chicago
Kawata, S., Yashima, K., Yamamoto, S., Sasaki, S., Takeda, Y., Hayashi, A., Matsumoto, K., Kawaguchi, K., Harada, K., Murawaki, Y."AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa". Oncology Letters 10, no. 2 (2015): 737-743. https://doi.org/10.3892/ol.2015.3342
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team